| Immunopathology of multiple sclerosis CA Dendrou, L Fugger, MA Friese Nature Reviews Immunology 15 (9), 545-558, 2015 | 2579 | 2015 |
| Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis JS Tzartos, MA Friese, MJ Craner, J Palace, J Newcombe, MM Esiri, ... The American journal of pathology 172 (1), 146-155, 2008 | 1517 | 2008 |
| N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both … SR Irani, K Bera, P Waters, L Zuliani, S Maxwell, MS Zandi, MA Friese, ... Brain 133 (6), 1655-1667, 2010 | 1160 | 2010 |
| A vaccine targeting mutant IDH1 induces antitumour immunity T Schumacher, L Bunse, S Pusch, F Sahm, B Wiestler, J Quandt, O Menn, ... Nature 512 (7514), 324-327, 2014 | 773 | 2014 |
| Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis MA Friese, B Schattling, L Fugger Nature Reviews Neurology 10 (4), 225-238, 2014 | 709 | 2014 |
| Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system MA Friese, MJ Craner, R Etzensperger, S Vergo, JA Wemmie, MJ Welsh, ... Nature medicine 13 (12), 1483-1489, 2007 | 481 | 2007 |
| Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke M Gelderblom, A Weymar, C Bernreuther, J Velden, P Arunachalam, ... Blood, The Journal of the American Society of Hematology 120 (18), 3793-3802, 2012 | 471 | 2012 |
| Neuronal vulnerability and multilineage diversity in multiple sclerosis L Schirmer, D Velmeshev, S Holmqvist, M Kaufmann, S Werneburg, ... Nature 573 (7772), 75-82, 2019 | 454 | 2019 |
| Frequent neurocognitive deficits after recovery from mild COVID-19 MS Woo, J Malsy, J Pöttgen, S Seddiq Zai, F Ufer, A Hadjilaou, ... Brain communications 2 (2), fcaa205, 2020 | 394 | 2020 |
| RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates … MA Friese, J Wischhusen, W Wick, M Weiler, G Eisele, A Steinle, M Weller Cancer research 64 (20), 7596-7603, 2004 | 377 | 2004 |
| Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? MA Friese, L Fugger Brain 128 (8), 1747-1763, 2005 | 348 | 2005 |
| MICA/NKG2D-mediated immunogene therapy of experimental gliomas MA Friese, M Platten, SZ Lutz, U Naumann, S Aulwurm, F Bischof, ... Cancer research 63 (24), 8996-9006, 2003 | 329 | 2003 |
| TGF-β and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells G Eisele, J Wischhusen, M Mittelbronn, R Meyermann, I Waldhauer, ... Brain 129 (9), 2416-2425, 2006 | 289 | 2006 |
| Pathogenic CD8+ T cells in multiple sclerosis MA Friese, L Fugger Annals of Neurology: Official Journal of the American Neurological …, 2009 | 274 | 2009 |
| T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides M Harkiolaki, SL Holmes, P Svendsen, JW Gregersen, LT Jensen, ... Immunity 30 (3), 348-357, 2009 | 246 | 2009 |
| Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis MA Friese, KB Jakobsen, L Friis, R Etzensperger, MJ Craner, ... Nature medicine 14 (11), 1227-1235, 2008 | 238 | 2008 |
| TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis B Schattling, K Steinbach, E Thies, M Kruse, A Menigoz, F Ufer, ... Nature medicine 18 (12), 1805-1811, 2012 | 223 | 2012 |
| Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model S Vergo, MJ Craner, R Etzensperger, K Attfield, MA Friese, J Newcombe, ... Brain 134 (2), 571-584, 2011 | 212 | 2011 |
| The value of animal models for drug development in multiple sclerosis MA Friese, X Montalban, N Willcox, JI Bell, R Martin, L Fugger Brain 129 (8), 1940-1952, 2006 | 204 | 2006 |
| The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2 S Krasemann, U Haferkamp, S Pfefferle, MS Woo, F Heinrich, ... Stem cell reports 17 (2), 307-320, 2022 | 187 | 2022 |
